One sentence summary: Serial passage of a virulent strain of Brachyspira hampsonii results in reduced virulence in a mouse model of infection.
INTRODUCTION
Swine dysentery re-emerged as a production limiting disease in North America in the mid-2000s (Burrough 2017) . This re-emergence has been associated with Brachyspira hampsonii, a Gram-negative, aerotolerant, strongly beta-hemolytic spirochaete. Brachyspira hampsonii was initially distinguished from other Brachyspira spp. based on sequence differences in the NADH-oxidase (nox) gene (Harding et al. 2010) , and has subsequently been proposed as a novel species (Chander et al. 2012) . Clinical isolates of B. hampsonii have demonstrated a high degree of virulence, leading to mucohemorrhagic diarrhea in experimentally inoculated pigs (Rubin et al. 2013a; Costa et al. 2014) .
Control of Brachyspira-associated diarrhea has proven challenging due to the complex ecology of the pathogens involved, their persistence in the environment (Olson 1995) and in animal reservoirs such as rodents (Backhans et al. 2013 ) and migratory waterfowl (Oxberry, Trott and Hampson 1998; Rubin et al. 2013b) . Depopulation can be effective in removing Brachyspira spp. from farms, but facilities remain at risk for reinfection due to these reservoirs of Brachyspira spp. Vaccines for B. hampsonii are needed to prevent outbreaks and contribute to regional eradication of the pathogen.
Several approaches to vaccine development have been pursued with varying success for B. hyodysenteriae, the historical cause of swine dysentery. Recombinant protein vaccines composed of outer membrane proteins have been shown to be partially protective in pig and mouse challenge experiments (La et al. 2004; Holden, Coloe and Smooker 2008) ; however, heterologous protection remains elusive since distribution of specific outer membrane proteins varies among B. hyodysenteriae isolates (Witchell et al. 2006; Holden, Coloe and Smooker 2008; Hidalgo et al. 2010) . Attempts to improve performance of outer membrane protein recombinant vaccines have involved strategies such as carrier microparticles coated with M cell targeting peptide, and modification of antigen proteins through fusion with unrelated domains (polyhistidine, maltose-binding protein, glutathione S-transferase) (Alonso et al. 2005; Holden, Coloe and Smooker 2008; Jiang et al. 2014) . Although serum from vaccinated pigs has been shown to recognize outer membrane extracts from multiple B. hyodysenteriae serotypes, in vivo serotype cross-protection has not yet been demonstrated (Lee et al. 2000; La et al. 2004) .
Live attenuated vaccines represent an alternative strategy, and commercial live attenuated vaccines are marketed for control of enteric swine pathogens Lawsonia intracellularis (Enterisol Ileitis, Boehringer Ingelheim) and Salmonella typhimurium and S. cholerasuis (Enterisol Salmonella TC, Boehringer Ingelheim). A challenge for live attenuated vaccine development for B. hampsonii is the lack of genetic tools for specific modification of genes, and a lack of knowledge of virulence determinants to target, even if it were possible to perform targeted manipulations. Random mutagenesis of virulent strains to produce live attenuated vaccine candidates is impractical due the large numbers of strains that would need to be screened in vivo. Laboratory attenuation through serial passage has proven to reduce the virulence of pathogens including Brachyspira hyodysenteriae, without specific knowledge of virulence determinants (Hudson et al. 1974 (Hudson et al. , 1976 . Serial passage of other bacterial species has been shown to lead to changes in genome structure, sequence alterations in a wide range of genes and associated phenotypic changes including adaptation to growth in laboratory culture and reduced production of virulence factors (Somerville et al. 2002; Fux et al. 2005) . Thus, in addition to producing a live attenuated vaccine candidate, attenuation by serial passage may also lead to identification of genomic determinants of virulence and thus a better understanding of pathogenesis.
The objective of the current study was to produce an attenuated B. hampsonii strain by serial passage of an isolate previously demonstrated to be virulent in pigs. Changes in phenotypic and genomic characteristics of the bacterium that occurred as a result of the attenuation process were assessed, and the effect of the attenuation process on virulence was determined in a mouse model.
MATERIALS AND METHODS

Brachypsira isolates and culture conditions
The strain selected for serial passaging was B. hampsonii D09-30446 passage 13 (P13), a clade II strain of B. hampsonii, which was originally isolated from intestinal contents of a 13-week old pig with mucohemorrhagic diarrhea (Rubin et al. 2013a Brachyspira spp. were cultured in BHIS broth (brain heart infusion (BHI) broth with 1% (w/v) glucose and 10% (v/v) fetal bovine serum) or JBS broth (BHI with 1% (w/v) glucose, 5% (v/v) deactivated fetal bovine serum and 5% (v/v) defibrinated sheep blood) in glass vials containing magnetic stir bars. Broth cultures were incubated at 39
• C under anaerobic conditions with constant stirring, using a commercial gas packet system (Anaerogen, Oxoid Limited, Basingstoke, UK). Long-term storage of Brachyspira isolates was in brain heart infusion (BHI) broth with 10% (v/v) glycerol at −80 • C.
Serial passage
The initial culture of B. hampsonii D09-30446 P13 was grown in 10 mL JBS in duplicate. For serial passages, 1 mL of broth culture was transferred to fresh JBS broth (9 mL) once a dense culture had been achieved (usually 1-3 days, but occasionally up to 6 days). The presence of active spirochaetes in the donor culture was confirmed by phase contrast microscopy prior to each passage. Periodically, Gram staining was performed on BHIS cultures grown from select JBS passage cultures, to check for obvious contaminants. The serial passage of P13 for 100 passages resulted in B. hampsonii D09-30446 passage 113 (P113). We chose 100 passages based on previous experiments showing attenuation of B. hyodysenteriae after at least 80 passages (Hudson et al. 1974; Halter and Joens 1988) 
Biochemical characterization
Brachyspira hampsonii P13 and P113 cultures were grown in BHIS broth to the mid-log phase. API-zym tests were performed according to the manufacturer's instructions, using cultures standardized to a turbidity of McFarland 5 (BioMérieux, St. Laurent, QC). Hippurate hydrolysis and indole spot tests were performed as previously described (Fellstrom and Gunnarsson 1995) . Brachyspira hyodysenteriae ATCC 27164 T and B. pilosicoli ATCC 51139 T were included as controls for the indole spot and hippurate hydrolysis tests.
Growth study
The growth rates of B. hampsonii P13 and P113 under laboratory conditions were compared. Three replicate cultures were prepared for each strain and each time point (0, 12, 24, 48, 60 and 72 h) . McFarland 5 standardized cultures (0.33 mL) were inoculated into 3.3 mL of BHIS broth, in glass culture vials (7 mL vials, 17 mm × 60 mm; VWR, Radnor, USA). Broth cultures were incubated at 39
• C with constant stirring, under anaerobic conditions.
At each time point, three replicate vials of P13 and P113 were harvested and optical density measurements at 600 nm (OD 600 ) were taken in polystyrene cuvettes using a spectrophotometer.
Random amplified polymorphic DNA genome fingerprinting
Random amplified polymorphic DNA (RAPD) fingerprinting was conducted using two different amplification primers as described by Quednau et al. (1998) and Jansson et al. (2004 • C for 10 min and a hold at 4
• C (Quednau et al. 1998) .
PCR products (10 μL of each reaction) were loaded into a 1.5% agarose gel, and run for 2.5 h at 100 V. The gel was stained with ethidium bromide, visualized and photographed under UV light. The resulting image was analyzed using Gel-Compar II software (Applied Maths, Austin, TX). Banding patterns were clustered using UPGMA clustering of Dice co-efficient with optimization and position tolerance settings of 0.00% and 1.00%, respectively.
Genome sequencing
Preparation of genomic DNA and sequencing libraries Genomic DNA was isolated from B. hampsonii P13 and P113 grown in BHIS broth medium using a modified salting out procedure (Martin-Platero et al. 2007) . Concentration of the genomic DNA extracts was measured using fluorometry (Qubit dsDNA BR kit, Life Technologies, Inc., Burlington, ON) and a spectrophotometer was used to obtain A 260 /A 280 ratios as an indicator of purity.
Preparation of mate-pair and paired-end sequencing libraries was conducted as described in the Illumina Nextera Mate Pair Sample Preparation Guide (Illumina, San Diego, CA) and Nextera XT DNA Library Prep Kit Reference Guide (Illumina), respectively. Average size of the final fragment libraries in base pairs (bp) was calculated using the DNA High-Sensitivity chip on the 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA) and concentrations in ng/μL assessed using fluorometry (Qubit dsDNA BR kit, Life Technologies, Inc.). Sequencing was performed in two runs on a MiSeq DNA sequencer using the 500 cycle (2 × 250) V2 Nano chemistry (Illumina).
Sequence data processing and identification of single nucleotide variants
Raw mate-pair and paired-end sequence reads in fastq format were trimmed for quality using Trimmomatic (Bolger, Lohse and Usadel 2014) with a minimum read length of 50 and quality score cut-off of 30. Mate-pair adapter sequences were identified and reads trimmed to the adapter location using NextClip (Leggett et al. 2014) , which results in classification of reads into four categories: (A) where the adapter is detected in both Read 1 and Read 2 of the mate-pair; (B) adapter in Read 2 only; (C) adapter in Read 1 only; (D) adapter not detected in either read. Reads from categories (A) to (C) were included in further analysis.
Mapping of mate-pair and paired-end reads on to the reference genome assembly for B. hampsonii strain 30446 (Genbank Accession NZ ALNZ00000000) and subsequent single nucleotide variant (SNV) analysis were conducted in Geneious R10 v. 10.2.2 (Biomatters, Ltd., Aukland, New Zealand).
Virulence assessment in mice
The experiments were designed and performed in accordance with the Canadian Council for Animal Care and all work was approved by the University of Saskatchewan Animal Research Ethics Board (protocol 20150015).
Experiment 1-P13 and P113
Twenty, six-week old, specific pathogen-free, female CF-1 mice (Charles River, Kingston, NY) were randomly assigned into groups of four mice per cage housed in high efficiency particulate air (HEPA)-filtered racks. The mice were individually identified using tail markings applied with a black marker and fed a low-zinc diet ad libitum (TD8540, Envigo, Indianapolis, IN) for the duration of the experiment. After one week of acclimatization, mice in each group were inoculated on each of three consecutive days with 0.3 mL (∼10 8 genomic equivalents/mL in JBS) of P13 (n = 8), P113 (n = 8) or sterile JBS culture medium (n = 4) intragastrically using a 20 gauge blunt-ended feeding needle. Feed was removed 6 h prior to inoculation. Health checks (hair condition, behavior) were performed twice daily. Mice were weighed on Days −6, −2, 0 (prior to inoculation), 5, 7, 9, 12, 14, 16 and at termination (Day 19 post-inoculation (PI)) for the calculation of average daily gain (ADG = total weight gained/number of days). Fecal pellets were collected for selective Brachyspira culture on BJ agar (Kunkle and Kinyon 1988) on Days −2, 0 (prior to inoculation), 5, 7, 9, 12, 14 and 16. Fecal scoring was performed twice a day (morning and afternoon) throughout the experiment. Fecal consistency was scored as: 0 = normal/formed, 1 = formed with slight mucus, 2 = formed with abundant mucus, 3 mild (3m) = mucus only/soft feces only, 3 severe (3s) = soft and very mucoid, 4 = soft and very mucoid with blood. Cecal tissue samples for B. hampsonii-specific quantitative PCR and histopathology, and cecal swabs for culture were collected at termination (Day 19 post-inoculation). For quantitative PCR, total DNA was purified from tissue samples using the DNeasy Blood and Tissue Kit (Qiagen, Mississauga, ON) and used as template in a clade-specific SYBR green quantitative PCR assay as described previously (Rubin et al. 2013a) . Cecum tissue samples were processed routinely for histological analysis of 5 μm hematoxylin and eosin stained (H&E) sections and slides were examined by a board certified veterinary pathologist blinded to treatment group. Histopathological lesion severity was assessed, including catarrhal inflammation and neutrophilic infiltration, graded semi-quantitatively from 0 to 3 and epithelial regeneration, graded as present or absent. Details of the scoring system are presented in Table 1 , Supporting Information.
Experiment 2-P13, P113 and MP1
Thirty, six-week old, specific pathogen-free, female CF-1 mice (Charles River) were randomly assigned into cages (two mice per cage) housed in HEPA-filtered racks. The mice were fed a low-zinc diet (TD8540). After one week of acclimatization, each mouse group was inoculated intragastrically on each of three consecutive days with 0.3 mL (∼10 8 genomic equivalents/mL in JBS) of P13 (n = 8), P113 (n = 8), MP1 (n = 8) or sterile JBS culture medium (n = 6). MP1 (mouse passage 1) was an isolate recovered from the colon of the mouse infected with P113 from Experiment 1 with the fewest abnormal fecal scores (mouse C3). MP1 was included to determine if passage through a mouse resulted in a change in the virulence of P113. Health checks, weight measurements, average daily gain (ADG) calculations and fecal pellet collection and culture were performed as described for Experiment 1. A modification to the fecal consistency scoring was made to add to the existing scoring system: score 0.5 = slightly soft, but formed. The second experiment ran for 19 days PI; however, the diet was changed from TD8540 to regular rodent chow on Day 13 due to the exhaustion of TD8540 stocks. For this reason, only the fecal score data collected from Days 0 to 14 were used for analysis to avoid any potential effects of the diet change on health and fecal outcomes. Post-termination quantification of B. hampsonii in tissues, terminal culture and histopathology are not reported for Experiment 2.
Statistics for Experiments 1 and 2
For Experiment 1, the mean ADG (a period from Day 0 to 19) for each group (P13, P113 or sham) were compared using the Kruskal-Wallis test. The average count of fecal scores ≥2 from Day 3 to 19 for each group (P13, P113 or sham), and the average percentage of Brachyspira positive fecal and terminal caecal culture samples were also compared by using the KruskalWallis test. Pairwise group comparisons were assessed using the Mann-Whitney U test. The average histopathologic score was calculated for each mouse across the five caecal sections; then, was compared by group using the Kruskal-Wallis and Dunn tests, with a post hoc Sidak test to control for multiple comparisons. The statistical analyses for Experiment 2 were similar to that of Experiment 1, except that the post-inoculation period was truncated at Day 14. Group comparisons were initially assessed using a Kruskal-Wallis test, and if positive, a post hoc Dunn test was performed controlled for multiple comparisons using a Sidak test.
Differences in the growth rates of P13 and P113 in culture were assessed using a Mann-Whitney U test by comparing the (OD 600 values), initially across all time points together, and then at separate time points. For these analyses, only time points between 0 and 60 h were statistically compared.
For all analyses, P < 0.05 was considered statistically significant a priori.
RESULTS
Serial passage
A total of 100 passages of P13 were done, resulting in strain P113. No contamination was detected during serial passage. No changes to morphology were noted in Gram stains and phasecontrast images of P13 and P113.
Biochemical characterization
To detect any changes to diagnostic biochemical characteristics, P13 and P113 were evaluated by API-zym, indole and hippurate hydrolysis tests. The API-zym assay resulted in positive β-glucosidase, negative α-galactosidase and negative α-glucosidase activities for both P13 and P113 (Table 1) . Negative hippurate hydrolysis and indole spot assay activities were also detected for both P13 and P113. The results for B. hyodysenteriae ATCC 27164 T (indole positive and hippurate negative) and B. pilosicoli ATCC 51139 T (indole negative and hippurate positive)
were as expected. P13 was α-chymotrypsin negative, but a positive result was obtained for P113. Additionally, a difference was observed in β-glucuronidase results, with P113 giving a weak positive result compared to the negative result for P13.
Growth study
To determine if serial passage had resulted in laboratory growth adaptation, the growth rates of P13 and P113 were compared. Exponential growth of P113 started after 12 h and the optical density of P113 cultures were greater than P13 cultures over the 72-h period (Fig. 1) . Exponential growth of P13 did not begin until after 24 h. P113 reached the stationary phase at approximately 48 h, while a stationary phase was not observed for P13 during the experiment. A significant group difference was detected between Table 1 . Biochemical profiles of P13 and P113.
P13 P113
Alkaline phosphatase P13 and P113 when time points 0, 12, 24, 48 and 60 h were considered (Mann-Whitney, P = 0.0488). Subsequent testing at individual time points indicated significant differences in OD 600 values at 12 (Mann-Whitney, P = 0.0495) and 24 h (Mann-Whitney, P = 0.0495).
Genome fingerprinting by RAPD
RAPD profiles of P13 and P113 were 96.3% and 94.1% identical to each other based on primers JH0724 or JH0725, respectively (Fig. 2) . RAPD patterns of B. hampsonii clade I strain 30599 and other species of Brachyspira spp. were easily distinguished from B. hampsonii clade II with only 47.1%-76.1% similarity to P13 and P113 depending on the species and the primer used.
Whole genome sequencing and SNV identification
Whole genome sequencing of P113 yielded a total of 909,529 raw mate-pair reads and 839,840 paired-end reads. For P13, 816,716 raw mate-pair reads and 1.6 million raw paired-end reads were obtained. Sequence data files have been deposited in the NCBI Sequence Read Archive (Bioproject Accessions PRJNA398575 and PRJNA413792). Following quality clipping of the P113 data, identification of paired reads and adapter trimming, 541,102 mate-pair and 783,794 paired-end reads were available for Bowtie2 mapping. Bowtie2 mapped >99% of reads to the B. hampsonii 30446 reference genome, with average coverage of 132×. SNV analysis was limited to identification of non-synonymous changes within predicted open reading frames, occurring with minimum 70% frequency and supported by a minimum 30× coverage. The reference genome sequence was derived from pyrosequencing data, which has a tendency to make errors in homopolymeric sequence regions. To address this limitation, the re-sequenced P13 genome served as a control in the SNV analysis and raw reads were mapped on to the reference genome to confirm any SNVs identified in P113. Using these parameters, five SNVs were identified in P113 in four genes predicted to encode DNA-directed RNA polymerase subunit beta, 30S ribosomal protein S2, a dicarboxylate/amino acid:cation symporter and a mannose-1-phosphate guanylyltransferase ( Table 2 ). The latter sequence was found to include the canonical signature motif of guanosine-diphospho-D-mannose pyrophosphorylase (GMP), GGXGXR(L)XPLX 5 PK (residues 10-26) (Sousa, Moreira and Leitao 2008) and was 32.4% identical (54.7% similar) to the GMP sequence of Thermotoga maritima, for which a crystal structure has been determined (Pelissier et al. 2010) . GMP enzymes catalyze the condensation of guanosine tri-phosphate and mannose-1-phosphate to form GDP-mannose, an essential precursor of mannose-containing polysaccharides in bacterial cell wall components including lipopolysaccharide (LPS). An alignment of the P113 sequence with its homolog in T. maritima highlighted the conservation of active site residues (Fig. 1, Supporting Information ). An examination of the crystal structure of T. maritima GMP (PDB accessions 2 × 60, 2 × 65, 2 × 5Z) showed that R144 (R146 in B. hampsonii) has hydrogen-bonding interactions with immediately adjacent active site residues. This arginine residue is changed to glycine in P113 due to the SNV described in Table 2 .
Virulence assessment in a mouse model
Experiment 1
Mouse behavior did not differ between the control, P13 and P113 groups. The calculated ADG also did not differ between groups (P = 0.65, Kruskal-Wallis/Mann-Whitney U test). A summary of fecal score results is shown in Fig. 3 . No abnormal fecal scores were observed during the acclimatization period, and fecal samples collected on Days −2 and 0 (prior to inoculation) were all culture negative. Fecal scores recorded during the morning and afternoon observation periods were frequently different for individual mice (Fig. 3A) . To compare fecal scores among groups, we defined a pathological fecal score as ≥2 (soft/mucoid, with or without blood). No fecal scores ≥2 were observed in control mice. The P13 and P113 mice both had more fecal scores ≥2 than control, and mice inoculated with P113 had significantly fewer observations of fecal scores ≥2 (average 5.5 ± 3.7) than those inoculated with P13 (11.4 ± 4.2) during the monitoring period (Days 3-19 post-inoculation) (P = 0.002, Kruskal-Wallis/MannWhitney U test; Fig. 3B ).
Although fecal score outcomes differed significantly between the P13 and P113 groups, no difference in fecal shedding of spirochetes was detected by culture. Fecal samples collected on Days 5, 7, 9, 12, 14 and 16 post-inoculation were cultured on BJ agar and scored as positive or negative based on the appearance of strong beta-hemolysis indicative of B. hampsonii growth. All samples from the control group were culture negative. Average percentage of culture positive samples for P13 and P113 groups were 72.5% (4.35/6 samples positive) and 65.0% (3.90/6 samples positive), respectively (P = 0.63, MannWhitney U test). Similarly, no difference in B. hampsonii DNA concentration detected in terminal cecum tissue samples by quantitative PCR was found between P13 and P113 groups (P = 0.13, Mann-Whitney U test). Brachyspira hampsonii qPCR results were positive for 5/8 P13 mice and 3/8 P113 mice. PCR positive samples from P13 mice and P113 mice contained an average of 7.58 ± 7.73 log 10 copies/g and 6.14 ± 6.38 log 10 copies/g, respectively. Fecal samples collected on the termination day were culture positive for 4/8 mice in each of the P13 and P113 groups. Five H&E stained sections, collected along the length of the cecum, were examined for each mouse. Each section was scored for catarrhal inflammation (0-3, where >1 indicates catarrhal colitis), neutrophilic infiltration (0-3, where >0 indicates neutrophilic inflammation) and epithelial regeneration (mitotic figures noted or not noted) . Average scores for each mouse were calculated and compared among control, P13 and P113 groups, with no significant differences detected.
Experiment 2
Mouse behavior did not differ among the sham, P13, P113 and MP1 groups. The calculated ADG also did not differ significantly between the groups (P = 0.23, Kruskal-Wallis/Dunn). A summary of fecal score results is shown in Fig. 3 . Fecal scores >0 were observed sporadically in 7/30 mice during the acclimatization period. Fecal samples collected on Days −2 and 0 (prior to inoculation) were all Brachyspira culture negative. As observed in Experiment 1, fecal scores recorded during the morning and afternoon observation periods were frequently different for individual mice (Fig. 3A) . One or two observations of fecal scores ≥2 were recorded during the post-inoculation monitoring period (Days 3-14 post-inoculation) for 5/6 control mice. Both the average fecal score and the number of abnormal fecal score observations per mouse in the P13 group were significantly higher than the other three groups, which did not differ from each other (P = 0.01, Kruskal-Wallis/Dunn; Fig. 3B) .
No difference in fecal shedding of spirochetes by the P13, P113 and MP1 groups was detected by culture. Fecal samples collected on Days 5, 7, 9, 12 and 14 post-inoculation were cultured on BJ agar and scored as positive or negative based on the appearance of strong beta-hemolysis indicative of B. hampsonii growth. All samples from the control group were culture negative. Average percentage of culture positive samples for P13, P113 and MP1 groups were 88.4%, 95.0% and 96.9%, respectively (P = 0.75, Kruskal-Wallis/Dunn). As described in the experimental methods, data beyond Day 14 post-inoculation, including data from terminal samples, were not included in the analysis due to the change in diet.
DISCUSSION
In vitro serial passage of a pathogenic B. hampsonii clade II strain D09-30446 was performed as a method of producing an attenuated vaccine candidate, and to identify potential genomic determinants of virulence. The potentially attenuated strain was evaluated based on diagnostic biochemical traits, growth rate and virulence in a mouse model. Feasibility of this study and the future studies of Brachyspira pathogenesis or evaluation of vaccine candidates is facilitated by the availability of an optimized mouse model of B. hampsonii colitis (Ek et al. 2017) , which reduces the cost and complexity of the inoculation experiments significantly relative to established pig models (Rubin et al. 2013a) .
Brachyspira spp. can be identified and somewhat differentiated based on a profile of biochemical markers (α-galactosidase, α-glucosidase, β-glucosidase, hippurate hydrolysis and indole production) combined with evaluation of hemolysis, although variation in these characteristics has been reported in several Brachyspira spp. (De Smet, Worth and Barrett 1998; Fellström et al. 1999; Mahu et al. 2016) including B. hampsonii (Perez et al. 2016) . Characterization of biochemical profiles of B. hampsonii P13 and P113 indicated no detectable changes in established diagnostic characteristics; however, differences in α-chymotrypsin and β-glucuronidase were observed. Variation in these particular tests among B. hampsonii isolates has not been reported, so the significance of this result is not known. Mutations of metabolic enzymes leading to attenuation of pathogenic bacteria have been reported, such as changes in glycerol dehydrogenase, an enzyme associated with virulence in Mycoplasma gallisepticum (Szczepanek et al. 2010) . The lack of detectable changes in diagnostic biochemical markers in our study was perhaps not surprising, since these historically characterized markers have not been linked to the level of pathogenicity of Brachyspira spp. (Achacha and Messier 1991; De Smet, Worth and Barrett 1998; Perez et al. 2016) . The most striking difference in phenotype resulting from serial passage was the adaptation of P113 to laboratory culture, demonstrated by its enhanced growth in JBS broth (Fig. 1) . This result was expected and has been observed for other bacteria serially passaged in the laboratory for extended periods since each passage results in selection of the most rapidly growing members of the population.
RAPD genome profiling can differentiate Brachyspira spp. (Jansson et al. 2004) . The application of RAPD profiling in our study demonstrated that this technique could also distinguish clades within B. hampsonii. RAPD profiles of clade II isolates P13 and P113 were easily distinguished from clade I strain 30599 (Fig. 2) . Clade II isolates P13 and P113 had virtually identical fingerprints, suggesting that no major chromosomal rearrangements or deletions occurred during serial passage. To investigate genome changes at a more detailed level, we determined the whole genome sequence of P113 and compared it to the P13 genome for the purpose of SNV identification. The most striking finding in the SNV analysis was the identification of a T → C change within the open reading frame of a predicted mannose-1-phosphate guanylytransferase enzyme, which results in an amino acid change, R146G (Table 2) . Based on our examination of the crystal structure of the orthologous enzyme in Thermotoga maritima (Pelissier et al. 2010) , this change would abrogate hydrogen-bonding interactions with immediately adjacent residues in the active site of the enzyme, presumably affecting the three-dimensional structure of the binding sites for substrate and the essential Mg 2+ co-factor.
In Salmonella, mannose-1-phosphate guanylytransferase activity is encoded by manC, a gene found within the rfb operon, which includes genes essential for O-antigen synthesis (Fitzgerald et al. 2003) . Mutations in manC in Salmonella enterica serovar Dublin cause a reduction in the production of LPS and virulence in a mouse model relative to wild type (Thomsen et al. 2003) . The carbohydrate composition of Brachyspira LPS is not known, although earlier efforts to characterize Brachyspira cell wall components suggested that it has a greatly reduced repeating O-antigen structure relative to other Gram negative organisms examined (Halter and Joens 1988) ; a characteristic that has resulted in its frequent description as lipo-oligosaccharide (LOS). LOS/LPS of Brachyspira is thought to be involved in causing the colonic lesions associated with B. hyodysenteriae (Nuessen, Joens and Glock 1983; Greer and Wannemuehler 1989) . Whole genome sequencing efforts have led to the identification of genes predicted to be responsible for LOS/LPS production in other Brachyspira species, both within the chromosome and on plasmids (Wanchanthuek et al. 2010) , and proteins predicted to be involved in LOS/LPS synthesis are among virulence factors identified in the surface proteome of B. hyodysenteriae and B. pilosicoli (Casas et al. 2016) . Taken together, this information suggests that the reduced virulence of P113 may be due to a defect in LOS/LPS synthesis. LOS/LPS is antigenic and its variable structure among Brachyspira strains may account for strain-specific immune responses (Wannemuehler, Hubbard and Greer 1988) , so whether an LOS/LPS mutant would cause sufficient immune stimulation to provide homologous or heterologous protection remains to be determined. The biological significance, if any, of SNV's in RNA polymerase, ribosomal protein S2 and a putative dicarboxylate/amino acid:cation symporter are not known, although it is possible that all of these could contribute to enhanced growth rate.
The results of two mouse inoculation experiments support the laboratory observations about P113 relative to its P13 ancestor. In both trials, significantly fewer observations of pathological fecal scores (≥2) were observed in P113 infected mice relative to P13 infected mice. No differences were observed; however, in fecal shedding of spirochetes between these groups in either experiment, or spirochete load in terminal tissues in the two groups in Experiment 1, indicating that whatever changes occurred to reduce virulence did not affect the ability of the organisms to colonize and replicate in the host. This is consistent with the observations of growth of P13 and P113 in the laboratory, where P113 showed enhanced growth rates in laboratory conditions (Fig. 1) .
Histopathological examination of cecum tissues from the mice showed no differences in catarrhal inflammation, neutrophilic infiltration and epithelial regeneration. We focused our observations on the cecum as this has been shown in other Brachyspira infections of mouse models to be a primary site of lesion development (Joens and Glock 1979; Suenaga and Yamazaki 1984; Nibbelink and Wannemuehler 1991; Nibbelink and Wannemuehler 1992; Burrough et al. 2012) . The examination of terminal tissues does not reflect the entire course of clinical disease and provides only a picture of the endpoint. In a previous study utilizing this mouse infection model, catarrhal inflammation, neutrophilic infiltration and epithelial regeneration were observed inconsistently in terminal tissue samples and lesion severity was not associated with clinical outcome (Ek et al. 2017) . The episodic nature of diarrhea associated with B. hampsonii infection we observed in mice (Fig. 3A) is typical of what is observed in the natural host, and this pattern likely contributes to relatively low frequency of detection of histopathologic lesions, and the spirochaete itself by culture and/or qPCR, in terminal samples. For this reason, fecal consistency changes and bacterial shedding during the post-inoculation period are preferred, non-invasive indicators of Brachyspira virulence and disease severity in pigs and mice (Rubin et al. 2013a; Costa et al. 2014; Ek et al. 2017) . They provide good indicators of disease progression and are easily and inexpensively monitored by research personnel.
Attenuation of pathogens may be achieved by passage through a novel host (Hanley 2011) , and evolution of opportunistic pathogens within their natural host can result in reduced virulence when direct host-host transmission occurs, eliminating requirement for environmental survival (Mikonranta et al. 2015) . Alternatively, passage of an attenuated strain may result in reversion to virulence due to back-mutations or the occurrence of compensatory mutations elsewhere in the genome (Detmer and Glenting 2006; Hanley 2011) . We isolated strain MP1 from the mouse in Experiment 1 that had the fewest abnormal fecal scores and included it in Experiment 2 to investigate the possibility that passage through mice might have further altered the virulence of this isolate. Results of Experiment 2, however, showed that MP1 could not be distinguished from P113 in terms of pathological fecal scores, or fecal shedding, and so we conclude that a single passage through a mouse did not result in a measurable change in virulence. Whether or not additional passages through mice or an alternative novel host would alter virulence is unknown.
One noteworthy difference in the results of the two infection experiments was that in Experiment 2, the P113 group was not different from control in terms of number of observations of abnormal fecal scores. This was most likely due to the observation of some abnormal fecal scores in the control group. In Experiment 1, fecal scores ≥2 were observed in control mice only immediately following inoculation. This difference in the results of the two experiments was somewhat surprising given that the same procedures were followed in both experiments, and mice in both experiments were obtained from the same supplier. Mice were supplied from a specific-pathogen free colony that is screened regularly to ensure freedom from pathogens including Salmonella spp. and Citrobacter rodentium, and all mice were culture negative for Brachyspira prior to inoculation, so the explanation for abnormal fecal scores in pre-inoculation mice and in the control group in Experiment 2 is not likely to be infection, but rather some unrecognized and unmeasured physiological or environmental factor.
Results of this study show that serial passage of a pathogenic swine isolate of B. hampsonii results in adaptation to laboratory culture and reduced virulence in mice with no apparent effect on bacterial colonization and shedding. The partial attenuation may be related to a mutation in the gene encoding a mannose-1-phosphate guanylytransferase enzyme predicted to be involved in production of LOS/LPS. Whether this isolate has similarly reduced virulence in the natural host, and whether colonization with P113 provides any protection against subsequent challenge with a more virulent isolate will be determined by ongoing swine challenge experiments.
